CS1205 Cesium Chloride (CsCl) Powder (CAS No. 7647-17-8)

SECTION 1. IDENTIFICATION

Product Name: Cesium Chloride

CAS #: 7647-17-8

Relevant identified uses of the substance: Scientific research and development

Supplier details:

Stanford Advanced Materials

E-mail: sales@samaterials.com

Tel: (949) 407-8904

Address: 23661 Birtcher Dr., Lake Forest, CA 92630 U.S.A.

SECTION 2. HAZARDS IDENTIFICATION

2.1 Classification of the substance or mixture

GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)

Acute toxicity, Oral (Category 4), H302

Reproductive toxicity (Category 2), H361

Specific target organ toxicity - repeated exposure (Category 2), H373

2.2 GHS Label elements, including precautionary statements

Pictogram

Signal word Warning

Hazard statement(s)

H302 Harmful if swallowed.

H361 Suspected of damaging fertility or the unborn child.

H373 May cause damage to organs through prolonged or repeated exposure.

Precautionary statement(s)

P201 Obtain special instructions before use.

P202 Do not handle until all safety precautions have been read and understood.P260 Do not breathe dust/ fume/ gas/ mist/ Vapors/ spray.

P264 Wash skin thoroughly after handling.

P270 Do not eat, drink or smoke when using this product.

P280 Wear protective gloves/ protective clothing/ eye protection/ face protection.

P301 + P312 + P330 IF SWALLOWED: Call a POISON CENTER or doctor/ physician if you feel

unwell. Rinse mouth.

P308 + P313 IF exposed or concerned: Get medical advice/ attention.

P405 Store locked up.

P501 Dispose of contents/ container to an approved waste disposal plant.

2.3 Hazards not otherwise classified (HNOC) or not covered by GHS - none

SECTION 3. COMPOSITION/INFORMATION ON INGREDIENTS

3.1 Substances

Formula : ClCs

Molecular weight : 168.36 g/mol

CAS-No. : 7647-17-8

EC-No. : 231-600-2

Hazardous components

Component / Classification / Concentration

Caesium chloride / Acute Tox. 4; Repr. 2; STOT RE 2; H302, H361, H373 / <= 100 %

SECTION 4. FIRST AID MEASURES

4.1 Description of first aid measures

General advice

Consult a physician. Show this safety data sheet to the doctor in attendance.Move out of dangerous

area.

If inhaled

If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a

physician.

In case of skin contact

Wash off with soap and plenty of water. Consult a physician.

In case of eye contact

Flush eyes with water as a precaution.

If swallowed

Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician.

4.2 Most important symptoms and effects, both acute and delayed

The most important known symptoms and effects are described in the labelling (see section 2.2)

and/or in section 11

4.3 Indication of any immediate medical attention and special treatment needed

No data available

SECTION 5. FIREFIGHTING MEASURES

5.1 Extinguishing media

Suitable extinguishing media

Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.

5.2 Special hazards arising from the substance or mixture

Hydrogen chloride gas, Cesium/cesium oxides5.3 Advice for firefighters

Wear self-contained breathing apparatus for firefighting if necessary.

5.4 Further information

No data available

SECTION 6. ACCIDENTAL RELEASE MEASURES

6.1 Personal precautions, protective equipment and emergency procedures

Use personal protective equipment. Avoid dust formation. Avoid breathing Vapors, mist or gas. Ensure

adequate ventilation. Evacuate personnel to safe areas. Avoid breathing dust.

For personal protection see section 8.

6.2 Environmental precautions

Prevent further leakage or spillage if safe to do so. Do not let product enter drains.

6.3 Methods and materials for containment and cleaning up

Pick up and arrange disposal without creating dust. Sweep up and shovel. Keep in suitable, closed

containers for disposal.

6.4 Reference to other sections

For disposal see section 13.

SECTION 7. HANDLING AND STORAGE

7.1 Precautions for safe handling

Avoid contact with skin and eyes. Avoid formation of dust and aerosols.Further processing of solid

materials may result in the formation of combustible dusts. The potential for combustible dust

formation should be taken into consideration before additional processing occurs.

Provide appropriate exhaust ventilation at places where dust is formed.

For precautions see section 2.2.

7.2 Conditions for safe storage, including any incompatibilities

Keep container tightly closed in a dry and well-ventilated place.

Hygroscopic.

Storage class (TRGS 510): Non Combustible Solids

7.3 Specific end use(s)

Apart from the uses mentioned in section 1.2 no other specific uses are stipulated

SECTION 8. EXPOSURE CONTROLS/PERSONAL PROTECTION

8.1 Control parameters

Components with workplace control parameters

Contains no substances with occupational exposure limit values.

8.2 Exposure controls

Appropriate engineering controls

Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks

and at the end of workday.

Personal protective equipment

Eye/face protection

Safety glasses with side-shields conforming to EN166 Use equipment for eye protection tested and

approved under appropriate government standards such as NIOSH (US) or EN 166(EU).

Skin protection

Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique

(without touching glove's outer surface) to avoid skin contact with this product. Dispose ofcontaminated gloves after use in accordance with applicable laws and good laboratory practices.

Wash and dry hands.

Complete suit protecting against chemicals, The type of protective equipment must be selected

according to

the concentration and amount of the dangerous substance at the specific workplace.

Respiratory protection

Where risk assessment shows air-purifying respirators are appropriate use a full-face particle

respirator type N100 (US) or type P3 (EN 143) respirator cartridges as a backup to engineering

controls. If the respirator is the sole means of protection, use a full-face supplied air respirator. Use

respirators and components tested and approved under appropriate government standards such as

NIOSH (US) or CEN (EU).

Control of environmental exposure

Prevent further leakage or spillage if safe to do so. Do not let product enter drains.

SECTION 9. PHYSICAL AND CHEMICAL PROPERTIES

9.1 Information on basic physical and chemical properties

a) Appearance Form: crystalline

Colour: colourless

b) Odor: odourless

c) Odor Threshold: No data available

d) pH: 6.0 - 7.5

e) Melting point/freezing point

Melting point/range: 645 °C (1,193 °F) - lit.

f) Initial boiling point and boiling range: 1,303 °C (2,377 °F) at 1,013 hPa (760 mmHg)

g) Flash point: N/A

h) Evaporation rate: No data available

i) Flammability (solid, gas): No data available

j) Upper/lower flammability or explosive limits: No data available

k) Vapor pressure: No data available

l) Vapor density: No data available

m) Relative density: 3.988 g/cm3

n) Water solubility 1,000 g/l at 20 °C (68 °F) - OECD Test Guideline 105 - soluble

o) Partition coefficient: noctanol/water: No data available

p) Auto-ignition temperature: > 400 °C (> 752 °F)

q) Decomposition temperature: No data available

r) Viscosity: No data available

s) Explosive properties: No data available

t) Oxidizing properties: No data available

9.2 Other safety information

Surface tension 72.8 mN/m at 1 at 20 °C (68 °F)

SECTION 10. STABILITY AND REACTIVITY

10.1 Reactivity

No data available

10.2 Chemical stability

Stable under recommended storage conditions.

10.3 Possibility of hazardous reactions

No data available

10.4 Conditions to avoidAvoid moisture.

10.5 Incompatible materials

Strong oxidizing agents, Strong acids

10.6 Hazardous decomposition products

Other decomposition products - No data available

In the event of fire: see section 5

SECTION 11. TOXICOLOGICAL INFORMATION

11.1 Information on toxicological effects

Acute toxicity

No data available

Inhalation: No data available

Dermal: No data available

No data available

Skin corrosion/irritation

No data available

Serious eye damage/eye irritation

No data available

Respiratory or skin sensitisation

No data available

Germ cell mutagenicity

reverse mutation assay

S. typhimurium

Result: negative

Mutagenicity (micronucleus test)

Mouse - male and female

Result: negative

Carcinogenicity

IARC: No component of this product present at levels greater than or equal to 0.1% is identified as

probable, possible or confirmed human carcinogen by IARC.

ACGIH: No component of this product present at levels greater than or equal to 0.1% is identified as a

carcinogen or potential carcinogen by ACGIH.

NTP: No component of this product present at levels greater than or equal to 0.1% is identified as a

known or anticipated carcinogen by NTP.

OSHA: No component of this product present at levels greater than or equal to 0.1% is identified as a

carcinogen or potential carcinogen by OSHA.Reproductive toxicity

Reproductive toxicity - Rat - Oral

Effects on Newborn: Growth statistics (e.g., reduced weight gain). Effects on Newborn: Biochemical

and metabolic.

Effects on Newborn: Physical.

No data available

Specific target organ toxicity - single exposure

No data available

Specific target organ toxicity - repeated exposure

No data available

Aspiration hazard

No data available

Additional Information

Repeated dose toxicity - Rat - male and female - Oral - No observed adverse effect level - 40 mg/kg

RTECS: FK9625000

To the best of our knowledge, the chemical, physical, and toxicological properties have not been

thoroughly investigated.Stomach - Irregularities - Based on Human Evidence

SECTION 12. ECOLOGICAL INFORMATION

12.1 Toxicity

No data available

12.2 Persistence and degradability

No data available

12.3 Bioaccumulative potential

No data available

12.4 Mobility in soil

No data available

12.5 Results of PBT and vPvB assessment

PBT/vPvB assessment not available as chemical safety assessment not required/not conducted

12.6 Other adverse effects

No data available

SECTION 13. DISPOSAL CONSIDERATIONS

13.1 Waste treatment methods

Product

Offer surplus and non-recyclable solutions to a licensed disposal company. Contact a licensed

professional waste disposal service to dispose of this material.

Contaminated packaging

Dispose of as unused product.

SECTION 14. TRANSPORT INFORMATION

DOT (US)

Not dangerous goods

IMDG

Not dangerous goods

IATA

Not dangerous goods

SECTION 15. REGULATORY INFORMATION

SARA 302 Components

No chemicals in this material are subject to the reporting requirements of SARA Title III, Section 302.

SARA 313 Components

This material does not contain any chemical components with known CAS numbers that exceed the

threshold (De

Minimis) reporting levels established by SARA Title III, Section 313.

SARA 311/312 Hazards

Acute Health Hazard, Chronic Health Hazard

Massachusetts Right To Know Components

No components are subject to the Massachusetts Right to Know Act.

Pennsylvania Right To Know ComponentsCaesium chloride

CAS-No.

7647-17-8

Revision Date

New Jersey Right To Know Components

Caesium chloride

CAS-No.

7647-17-8

Revision Date

California Prop. 65 Components

This product does not contain any chemicals known to State of California to cause cancer, birth

defects, or any other reproductive harm.

SECTION 16. OTHER INFORMATION

Safety Data Sheet according to Regulation (EC) No. 1907/2006 (REACH). The above information is

believed to be correct but does not purport to be all inclusive and shall be used only as a guide. The

information in this document is based on the present state of our knowledge and is applicable to the

product with regard to appropriate safety precautions. It does not represent any guarantee of the

properties of the product.